PaperTrue

     恭喜清华大学电子工程系余佳东团队喜中ADVANCED MATERIALS(IF:25.8),购买服务为:优质润色 点击查看更多发表案例
以下是对 DRUGS R&D 杂志介绍 收藏
缩写名/全名
DRUGS R&D
DRUGS IN R&D
ISSN号 1174-5886
研究方向 Pharmacology, Toxicology and Pharmaceutics-Pharmacology
影响因子 2015:0, 2016:0, 2017:0, 2018:, 2019:2.277,
出版国家 New Zealand
出版周期 4 issues a year, 2010-
年文章数 32
出版年份 0
是否OA Yes
审稿周期(仅供参考)
录用比例
投稿链接 https://www.editorialmanager.com/drda/default.aspx
投稿官网 http://link.springer.com/journal/40268
h-index 39
CiteScore
CiteScoreSJRSNIPCiteScore排名
4.200.5850.986
学科分区排名
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q2124 / 301

PubMed Central (PMC)链接 http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1174-5886%5BISSN%5D
中科院SCI期刊分区
( 2018年新版本)
中科院SCI期刊分区
( 2020年新版本)
  • 该杂志上中国学者近期发表的论文
  • 同领域相关期刊
中国学者近期发表的论文
1.Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension

Author: Qi-Fang Huang, , Chang-Sheng Sheng, Yan Li, Gen-Shan Ma, Qiu-Yan Dai, Ji-Guang Wang
Journal: Drugs in research & development, 2013, Vol.13, 109-117, DOI:10.1007/s40268-013-0013-9
    DOI
2.Bioequivalence and Pharmacokinetic Evaluation of Two Formulations of Risperidone 2 mg

Author: Yun Liu, Meng-qi Zhang, Jing-ying Jia, Yan-mei Liu, Gang-yi Liu, Shui-jun Li, Wei Wang, Li-ping Weng, Chen Yu
Journal: Drugs in research & development, 2013, Vol.13, 29-36, DOI:10.1007/s40268-012-0002-4
    DOI
3.Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension

Author: Qi-Fang Huang, , Chang-Sheng Sheng, Yan Li, Gen-Shan Ma, Qiu-Yan Dai, Ji-Guang Wang
Journal: Drugs in research & development, 2013, Vol.13, 109-117, DOI:10.1007/s40268-013-0013-9
    DOI
4.Pharmacokinetics of Cefozopran by Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers

Author: G. L. Wu, J. Z. Shentu, H. L. Zhou, M. X. Zhu, X. J. Hu, J. Liu, L. H. Wu
Journal: Drugs in research & development, 2015, Vol.15, 63-70, DOI:10.1007/s40268-014-0075-3
    DOI
5.A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus

Author: Changyu Pan, Jorge L. Gross, Wenying Yang, Xiaofeng Lv, Li Sun, Charlotte Thim Hansen, Hongfei Xu, Robert Wagner
Journal: Drugs in research & development, 2016, Vol.16, 239-249, DOI:10.1007/s40268-016-0134-z
    DOI
同类著名期刊名称 h-index CiteScore
Vaccines04.50
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy352.70
INDIAN JOURNAL OF PHARMACOLOGY02.10
BULLETIN OF PHARMACEUTICAL SCIENCES00.00
中科院JCR同大类学科的热搜期刊 浏览次数
此期刊未被最新的JCR收录